Sex Differences in Circulating Progenitor Cells

BackgroundLower levels of circulating progenitor cells (PCs) reflect impaired endogenous regenerative capacity and are associated with aging, vascular disease, and poor outcomes. Whether biologic sex and sex hormones influence PC numbers remains a subject of controversy. We sought to determine sex d...

Full description

Bibliographic Details
Main Authors: Matthew L. Topel, Salim S. Hayek, Yi‐An Ko, Pratik B. Sandesara, Ayman Samman Tahhan, Iraj Hesaroieh, Ernestine Mahar, Greg S. Martin, Edmund K. Waller, Arshed A. Quyyumi
Format: Article
Language:English
Published: Wiley 2017-10-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.117.006245
_version_ 1811332630990290944
author Matthew L. Topel
Salim S. Hayek
Yi‐An Ko
Pratik B. Sandesara
Ayman Samman Tahhan
Iraj Hesaroieh
Ernestine Mahar
Greg S. Martin
Edmund K. Waller
Arshed A. Quyyumi
author_facet Matthew L. Topel
Salim S. Hayek
Yi‐An Ko
Pratik B. Sandesara
Ayman Samman Tahhan
Iraj Hesaroieh
Ernestine Mahar
Greg S. Martin
Edmund K. Waller
Arshed A. Quyyumi
author_sort Matthew L. Topel
collection DOAJ
description BackgroundLower levels of circulating progenitor cells (PCs) reflect impaired endogenous regenerative capacity and are associated with aging, vascular disease, and poor outcomes. Whether biologic sex and sex hormones influence PC numbers remains a subject of controversy. We sought to determine sex differences in circulating PCs in both healthy persons and patients with coronary artery disease, and to determine their association with sex hormone levels. Methods and ResultsIn 642 participants (mean age 48 years, 69% women, 23% black) free from cardiovascular disease, we measured circulating PC counts as CD45med+ mononuclear cells coexpressing CD34 and its subsets expressing CD133, chemokine (C‐X‐C motif) receptor 4, and vascular endothelial growth factor receptor 2 epitopes using flow cytometry. Testosterone and estradiol levels were measured. After adjustment for age, cardiovascular risk factors, and body mass, CD34+ (β=−23%, P<0.001), CD34+/CD133+ (β=−20%, P=0.001), CD34+/chemokine (C‐X‐C motif) receptor 4–positive (β=−24%, P<0.001), and CD34+/chemokine (C‐X‐C motif) receptor 4–positive/CD133+ (β=−21%, P=0.001) PC counts, but not vascular endothelial growth factor receptor 2‐positive PC counts were lower in women compared with men. Estradiol levels positively correlated with hematopoietic, but not vascular endothelial growth factor receptor 2‐ positive PC counts in women (P<0.05). Testosterone levels and PC counts were not correlated in men. These findings were replicated in an independent cohort with prevalent coronary artery disease. ConclusionsWomen have lower circulating hematopoietic PC levels compared with men. Estrogen levels are modestly associated with PC levels in women. Since PCs are reflective of endogenous regenerative capacity, these findings may at least partly explain the rise in adverse cardiovascular events in women with aging and menopause.
first_indexed 2024-04-13T16:39:51Z
format Article
id doaj.art-46f4d32505684a94b70bbe5ca914c4d5
institution Directory Open Access Journal
issn 2047-9980
language English
last_indexed 2024-04-13T16:39:51Z
publishDate 2017-10-01
publisher Wiley
record_format Article
series Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
spelling doaj.art-46f4d32505684a94b70bbe5ca914c4d52022-12-22T02:39:16ZengWileyJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease2047-99802017-10-0161010.1161/JAHA.117.006245Sex Differences in Circulating Progenitor CellsMatthew L. Topel0Salim S. Hayek1Yi‐An Ko2Pratik B. Sandesara3Ayman Samman Tahhan4Iraj Hesaroieh5Ernestine Mahar6Greg S. Martin7Edmund K. Waller8Arshed A. Quyyumi9Division of Cardiology, Emory University School of Medicine, Atlanta, GADivision of Cardiology, Emory University School of Medicine, Atlanta, GADepartment of Biostatistics and Bioinformatics, Emory University, Atlanta, GADivision of Cardiology, Emory University School of Medicine, Atlanta, GADivision of Cardiology, Emory University School of Medicine, Atlanta, GADepartment of Hematology and Oncology, Winship Cancer Institute, Emory University, Atlanta, GADepartment of Hematology and Oncology, Winship Cancer Institute, Emory University, Atlanta, GADepartment of Pulmonary, Allergy, Critical Care and Sleep Medicine, Emory University, Atlanta, GADepartment of Hematology and Oncology, Winship Cancer Institute, Emory University, Atlanta, GADivision of Cardiology, Emory University School of Medicine, Atlanta, GABackgroundLower levels of circulating progenitor cells (PCs) reflect impaired endogenous regenerative capacity and are associated with aging, vascular disease, and poor outcomes. Whether biologic sex and sex hormones influence PC numbers remains a subject of controversy. We sought to determine sex differences in circulating PCs in both healthy persons and patients with coronary artery disease, and to determine their association with sex hormone levels. Methods and ResultsIn 642 participants (mean age 48 years, 69% women, 23% black) free from cardiovascular disease, we measured circulating PC counts as CD45med+ mononuclear cells coexpressing CD34 and its subsets expressing CD133, chemokine (C‐X‐C motif) receptor 4, and vascular endothelial growth factor receptor 2 epitopes using flow cytometry. Testosterone and estradiol levels were measured. After adjustment for age, cardiovascular risk factors, and body mass, CD34+ (β=−23%, P<0.001), CD34+/CD133+ (β=−20%, P=0.001), CD34+/chemokine (C‐X‐C motif) receptor 4–positive (β=−24%, P<0.001), and CD34+/chemokine (C‐X‐C motif) receptor 4–positive/CD133+ (β=−21%, P=0.001) PC counts, but not vascular endothelial growth factor receptor 2‐positive PC counts were lower in women compared with men. Estradiol levels positively correlated with hematopoietic, but not vascular endothelial growth factor receptor 2‐ positive PC counts in women (P<0.05). Testosterone levels and PC counts were not correlated in men. These findings were replicated in an independent cohort with prevalent coronary artery disease. ConclusionsWomen have lower circulating hematopoietic PC levels compared with men. Estrogen levels are modestly associated with PC levels in women. Since PCs are reflective of endogenous regenerative capacity, these findings may at least partly explain the rise in adverse cardiovascular events in women with aging and menopause.https://www.ahajournals.org/doi/10.1161/JAHA.117.006245CD133CD34CXCR4estrogenprogenitor cellvascular endothelial growth factor receptor 2
spellingShingle Matthew L. Topel
Salim S. Hayek
Yi‐An Ko
Pratik B. Sandesara
Ayman Samman Tahhan
Iraj Hesaroieh
Ernestine Mahar
Greg S. Martin
Edmund K. Waller
Arshed A. Quyyumi
Sex Differences in Circulating Progenitor Cells
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
CD133
CD34
CXCR4
estrogen
progenitor cell
vascular endothelial growth factor receptor 2
title Sex Differences in Circulating Progenitor Cells
title_full Sex Differences in Circulating Progenitor Cells
title_fullStr Sex Differences in Circulating Progenitor Cells
title_full_unstemmed Sex Differences in Circulating Progenitor Cells
title_short Sex Differences in Circulating Progenitor Cells
title_sort sex differences in circulating progenitor cells
topic CD133
CD34
CXCR4
estrogen
progenitor cell
vascular endothelial growth factor receptor 2
url https://www.ahajournals.org/doi/10.1161/JAHA.117.006245
work_keys_str_mv AT matthewltopel sexdifferencesincirculatingprogenitorcells
AT salimshayek sexdifferencesincirculatingprogenitorcells
AT yianko sexdifferencesincirculatingprogenitorcells
AT pratikbsandesara sexdifferencesincirculatingprogenitorcells
AT aymansammantahhan sexdifferencesincirculatingprogenitorcells
AT irajhesaroieh sexdifferencesincirculatingprogenitorcells
AT ernestinemahar sexdifferencesincirculatingprogenitorcells
AT gregsmartin sexdifferencesincirculatingprogenitorcells
AT edmundkwaller sexdifferencesincirculatingprogenitorcells
AT arshedaquyyumi sexdifferencesincirculatingprogenitorcells